NCT07414836 2026-02-17
A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors
BeOne Medicines
Phase 1 Not yet recruiting
Clinical Trials
11 trialsNCT07408258 2026-02-13
Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors
OncoC4, Inc.
Phase 1 Not yet recruiting
NCT07380334 2026-02-02
A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Not yet recruiting
NCT07348653 2026-01-21
A Study of MG2512 Injection in Participants With Advanced Solid Tumors
Shanghai Mabgen Biopharmaceutical Technology Co., Ltd.
Phase 1 Not yet recruiting
NCT06872580 2025-03-12
A Study of QLS1209 in theTreatment of Patients With Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT06779045 2025-01-16
A Study of AK-1286 in Patients With Advanced Solid Tumors
Shanghai YingLi Pharmaceutical Co. Ltd.
Phase 1 Not yet recruiting
NCT06621615 2024-10-01
Clinical Study of CVL006 Injection in Advanced Solid Tumors
Convalife (Shanghai) Co., Ltd.
Phase 1 Not yet recruiting
NCT05933668 2023-07-06
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Solid Tumor
Peking University
Phase 1 Not yet recruiting
NCT05924906 2023-07-03
A Dose Escalation and Expansion Study of NB002 in Participants With Advanced or Metastatic Solid Tumors
Suzhou Neologics Bioscience Co., Ltd.
Phase 1 Not yet recruiting
NCT05766527 2023-03-13
A Study of KM602 in Patients With Advanced Solid Tumors
Xuanzhu Biopharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT05320874 2022-04-11
A Study of KM257 in Patients With Advanced HER2-positive or Expressing Solid Tumors.
Xuanzhu Biopharmaceutical Co., Ltd.
Phase 1 Not yet recruiting